Format

Send to

Choose Destination
Mol Ther Oncolytics. 2018 Dec 12;11:122-126. doi: 10.1016/j.omto.2018.11.002. eCollection 2018 Dec 21.

Exploiting Oncogenic Drivers along the CCNG1 Pathway for Cancer Therapy and Gene Therapy.

Author information

1
The Cancer Center of Southern California/Sarcoma Oncology Center, Santa Monica, CA 90403, USA.
2
Delta Next-Gene, LLC, Santa Monica, CA 90403, USA.
3
Aveni Foundation, Santa Monica CA 90403, USA.

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center